<code id='5B67CC8CAB'></code><style id='5B67CC8CAB'></style>
    • <acronym id='5B67CC8CAB'></acronym>
      <center id='5B67CC8CAB'><center id='5B67CC8CAB'><tfoot id='5B67CC8CAB'></tfoot></center><abbr id='5B67CC8CAB'><dir id='5B67CC8CAB'><tfoot id='5B67CC8CAB'></tfoot><noframes id='5B67CC8CAB'>

    • <optgroup id='5B67CC8CAB'><strike id='5B67CC8CAB'><sup id='5B67CC8CAB'></sup></strike><code id='5B67CC8CAB'></code></optgroup>
        1. <b id='5B67CC8CAB'><label id='5B67CC8CAB'><select id='5B67CC8CAB'><dt id='5B67CC8CAB'><span id='5B67CC8CAB'></span></dt></select></label></b><u id='5B67CC8CAB'></u>
          <i id='5B67CC8CAB'><strike id='5B67CC8CAB'><tt id='5B67CC8CAB'><pre id='5B67CC8CAB'></pre></tt></strike></i>

          Home / Wikipedia / explore

          explore


          explore

          author:Wikipedia    Page View:92459
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In